Ofatumumab: a guide to its use in chronic lymphocytic leukaemia

Author： Keating Gillian M.   Lyseng-Williamson Katherine A.   Sanford Mark   McCormack Paul L.  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.6, 2012-06, pp. : 6-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Plosker G.L.   Figgitt D.P.  

Drugs, Vol. 63, Iss. 8, 2003-01 ,pp. : 803-843

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Cvetković Risto S.   Perry Caroline M.  

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 791-820

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

By Hoy Sheridan M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1929-1950

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

By Keating Gillian M.  

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1445-1476

Adis International

Access to resources Recommend Favorite

Management of Chronic Lymphocytic Leukaemia

By Kalil N.   Cheson B.D.  

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite